Ledger.Open graph →
SEC Form D · filed March 3, 2017

Illustris Pharmaceuticals Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mark Prygocki · Palo Alto, CAExec · DirectorJacob M. Waugh · Palo Alto, CAExec · DirectorAndrew K. Hirschberg · Palo Alto, CADirectorJonah K. Shacknai · Palo Alto, CADirectorJaehoon M. Lee · Palo Alto, CAExecSiak K. Tan · Palo Alto, CADirectorGloria M. Vasquez · Palo Alto, CAExecAndrew K. Hirschberg · Palo Alto, CADirectorJonah K. Shacknai · Palo Alto, CADirectorJaehoon M. Lee · Palo Alto, CAExecMark Prygocki · Palo Alto, CAExec · DirectorJacob M. Waugh · Palo Alto, CAExec · DirectorSiak K. Tan · Palo Alto, CADirectorGloria M. Vasquez · Palo Alto, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗